Semaglutide for CVD in Diabetes, PAD, and MASH, Semaglutide vs Tirzepatide, Normal Saline vs Lactated Ringer's, Oxygen Targets for Intubated Patients, Platelet Transfusion Guidelines, Apixaban vs Rivaroxaban

About this episode

The episode discusses recent trials related to semaglutide and its comparisons with tirzepatide, along with critical care studies and guidelines for platelet transfusions and anticoagulants.

Today we do a round-up of some of the recent semaglutide trials. Does semaglutide ever miss? But what about tirzepatide, which causes even more weight loss? We also review two new critical care trials, FLUID and the UK-ROX, new platelet transfusion guidelines, and a new retrospective study of apixaban vs rivaroxaban vs warfarin. Oral Semaglutide for Diabetes with Cardiovascular Disease or CKD (SOUL) Semaglutide for Peripheral Artery Disease (STRIDE) Semaglutide for MASH (ESSENCE) Semagl...

People in this episode

Hosts: Stephen Jenkins, MD, Austin Rupp, MD

Topics covered

• semaglutide trials
• weight loss medications
• critical care trials
• platelet transfusion guidelines
• anticoagulants comparison

Keywords

• semaglutide
• tirzepatide
• critical care
• platelet transfusion
• apixaban
• rivaroxaban
• diabetes
• CVD
• PAD

Mentioned in this episode

Products: Semaglutide, Tirzepatide, Normal Saline, Lactated Ringer's, Apixaban, Rivaroxaban

More episodes of Last Week in Medicine

• Catheter Directed Fibrinolysis for Acute PE (HI-PEITHO), NEWS2 Plus Procalcitonin Reduces Mortality (PRONTO) · April 7, 2026 · 1h 1m
• Bleeding Risk with Apixaban vs Rivaroxaban for Acute VTE (COBRRA), Left Atrial Appendage Closure vs Medical Therapy for Atrial Fibrillation (CLOSURE-AF) · March 28, 2026 · 36 min
• 2026 ACC/AHA Guidelines for Acute Pulmonary Embolism · March 11, 2026 · 48 min
• Hematopoietic Stem Cell Gene Therapy for Cystinosis · March 3, 2026 · 42 min
• Extended Apixaban for Provoked VTE (HI-PRO), Coffee and Atrial Fibrillation (DECAF), Age-Adjusted D-dimer for DVT, Beta Blockers after MI with Normal EF, Fish Oil for Dialysis (PISCES), Conservative Dialysis for AKI (LIBERATE-D) · February 25, 2026 · 1h 11m
• Hydrocortisone for Severe Pneumonia (REMAP-CAP), Intensive BP Control in Diabetes (BPROAD), Aldosterone Synthase Inhibitors for Hypertension (ADVANCE-HTN), Reduced-dose Apixaban for Cancer Associated Thrombosis (API-CAT) · April 24, 2025 · 57 min